{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T20:46:24Z","timestamp":1649018784387},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1985,1]]},"DOI":"10.1007\/bf01644214","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T03:33:08Z","timestamp":1115436788000},"page":"S28-S33","source":"Crossref","is-referenced-by-count":2,"title":["Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms"],"prefix":"10.1007","volume":"13","author":[{"given":"C. J.","family":"Schleupner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1128\/AAC.16.1.64","volume":"16","author":"G. W. Counts","year":"1979","unstructured":"Counts, G. W., Turck, M. Antibacterial activity of a new parenteral cephalosporin \u2014 HR 756: comparison with cefamandole and ceforanide. Antimicrob. Agents Chemother. 16 (1979) 64\u201368.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jac\/4.5.437","volume":"4","author":"J. M. T. Hamilton-Miller","year":"1978","unstructured":"Hamilton-Miller, J. M. T., Brumfitt, W., Reynolds, A. V. Cefotaxime (HR 756), a new cephalosporin with exceptional broad-spectrum activityin vitro. J. Antimicrob. Chemother. 4 (1978) 437\u2013444.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/AAC.17.3.474","volume":"17","author":"P. R. Murray","year":"1980","unstructured":"Murray, P. R. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistantPseudomonas. Antimicrob. Agents Chemother. 17 (1980) 474\u2013476.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/AAC.15.2.273","volume":"15","author":"H. C. Neu","year":"1979","unstructured":"Neu, H. C., Aswapokee, N., Aswapokee, P., Fu, K. P. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 15 (1979) 273\u2013281.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/AAC.14.6.876","volume":"14","author":"J. P. Sosna","year":"1978","unstructured":"Sosna, J. P., Murray P. R., Medoff, G. Comparison of thein vitro activities of HR 756 with cephalothin, cefoxitin, and cefamandole. Antimicrob. Agents Chemother. 14 (1978) 876\u2013879.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.16.6.757","volume":"16","author":"R. P. Mouton","year":"1979","unstructured":"Mouton, R. P., Bongaerts, G. P. A., van Gestel, M. Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins. Antimicrob. Agents Chemother. 16 (1979) 757\u2013760.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000237902","volume":"26","author":"G. Peters","year":"1980","unstructured":"Peters, G., Pulverer, G. Comparativein vitro activity of cefotaxime (HR 756). Chemotherapy 26 (1980) 177\u2013183.","journal-title":"Chemotherapy"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jac\/7.6.629","volume":"7","author":"C. H. Ramirez-Ronda","year":"1981","unstructured":"Ramirez-Ronda, C. H., Nevarez, M., Saavedra, S., Bermudez, R. H. Comparativein vitro activity of moxalactam and cefotaxime againist isolates from blood culture. J. Antimicrob. Chemother. 7 (1981) 629\u2013635.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/AAC.21.6.925","volume":"21","author":"H. L. Muytjens","year":"1982","unstructured":"Muytjens H. L., van der Ros-van de Repe, J. Comparative activities of 13 \u00df-lactam antibiotics. Antimicrob. Agents Chemother. 21 (1982) 925\u2013934.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7326\/0003-4819-97-3-408","volume":"97","author":"H. C. Neu","year":"1982","unstructured":"Neu, H. C. The new beta-lactamase-stable cephalosporins. Ann. Intern. Med. 97 (1982) 408\u2013419.","journal-title":"Ann. Intern. Med."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/AAC.19.5.794","volume":"19","author":"S. H. Landesman","year":"1981","unstructured":"Landesman, S. H., Corrado, M. L., Cherubin, C. E., Sierra, M. F. Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin aganinst group B streptococci. Antimicrob. Agents Chemother. 19 (1981) 794\u2013797.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.20.4.553","volume":"20","author":"C. E. Cherubin","year":"1981","unstructured":"Cherubin, C. E., Corrado, M. L., Sierra, M. F., Gombert, M. E., Shulman, M. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, andN-formimidoyl thienamycin. Antimicrob. Agents Chemother. 20 (1981) 553\u2013555.","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl.","key":"CR13","doi-asserted-by":"crossref","first-page":"S708","DOI":"10.1093\/clinids\/4.Supplement_3.S708","volume":"4","author":"R. C. Moellering Jr.","year":"1982","unstructured":"Moellering, R. C., Jr. Enterococcal infections in patients treated with moxalactam. Rev. Infect. Dis. 4 Suppl. (1982) S708-S711.","journal-title":"Rev. Infect. Dis."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-94-6-784","volume":"94","author":"V. Yu","year":"1981","unstructured":"Yu, V. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad spectrum antibiotic. Ann. Intern. Med. 94 (1981) 784\u2013785.","journal-title":"Ann. Intern. Med."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1016\/0732-8893(84)90026-9","volume":"2","author":"C. Thornsberry","year":"1984","unstructured":"Thornsberry, C., Sahm, D. F. Effect of media and blood on the antimicrobial activity of cephalosporins on serogroup D streptococci: a review. Diag. Microbial. Infect. Dis. 2 (1984) 75S-84S.","journal-title":"Diag. Microbial. Infect. Dis."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0002-9343(81)90173-X","volume":"71","author":"E. L. Francke","year":"1981","unstructured":"Francke, E. L., Neu, H. C. Use of cefotaxime, a\u03b2-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms. Am. J. Med. 71 (1981) 435\u2013442.","journal-title":"Am. J. Med."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/AAC.21.2.327","volume":"21","author":"C. J. Schleupner","year":"1982","unstructured":"Schleupner, C. J., Engle, J. C. Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections. Antimicrob. Agents Chemother. 21 (1982) 327\u2013333.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archinte.1983.00350090079013","volume":"143","author":"D. T. Mullaney","year":"1983","unstructured":"Mullaney, D. T., John, J. F. Cefotaxime therapy. Evaluation of its effect on bacterial meningitis, CSF drug levels, and bactericidal activity. Arch. Intern. Med. 143 (1983) 1705\u20131708.","journal-title":"Arch. Intern. Med."},{"issue":"Suppl.","key":"CR19","doi-asserted-by":"crossref","first-page":"S411","DOI":"10.1093\/clinids\/4.Supplement_2.S411","volume":"4","author":"B. R. Meyers","year":"1982","unstructured":"Meyers, B. R. Clinical experience with cefotaxime in the treatment of patients with bacteremia. Rev. Infect. Dis. 4 Suppl. (1982) S411-S415.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl.","key":"CR20","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/clinids\/4.Supplement_2.S416","volume":"4","author":"P. O. Madsen","year":"1982","unstructured":"Madsen, P. O. Treatment of urinary tract infections with cefotaxime: noncomparative and prospective comparative trials. Rev. Infect. Dis. 4 Suppl. (1982) S416-S420.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl.","key":"CR21","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1093\/clinids\/4.Supplement_2.S421","volume":"4","author":"R. L. Perkins","year":"1982","unstructured":"Perkins, R. L. Clinical trials of cefotaxime for the treatment of bacterial infections of the lower respiratory tract. Rev. Infect. Dis. 4 Suppl. (1982) S421-S431.","journal-title":"Rev. Infect. Dis."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/AAC.23.3.429","volume":"23","author":"B. Kemmerich","year":"1983","unstructured":"Kemmerich, B., Lode, H., Belmega, G., Jendroschek, T., Borner, K., Koeppe, P. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Antimicrob. Agents Chemother. 23 (1983) 429\u2013434.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR23","first-page":"13S","volume":"2","author":"E. Schrinner","year":"1984","unstructured":"Schrinner, E., Limbert, M., Seeger, K., Seibert, G., Novick, W. J., Jr. Thein vitro antimicrobial activity of desacetyl-cefotaxime compared to other related\u03b2-lactams. Diag. Microbiol. Infect. Dis. 2 (1984) 13S-20S.","journal-title":"Diag. Microbiol. Infect. Dis."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/0732-8893(84)90021-X","volume":"2","author":"R. N. Jones","year":"1984","unstructured":"Jones, R. N., Barry, A. L., Packer, R. R. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci. Diag. Microbiol. Infect. Dis. 2 (1984) 37S-46S.","journal-title":"Diag. Microbiol. Infect. Dis."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","volume":"45","author":"A. W. Bauer","year":"1966","unstructured":"Bauer, A. W., Kirby, W. M. M., Sherris, J. C., Turck, M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45 (1966) 493\u2013496.","journal-title":"Am. J. Clin. Pathol."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.18.1.88","volume":"18","author":"P. C. Fuchs","year":"1980","unstructured":"Fuchs, P. C., Barry, A. L., Thornsberry, C., Jones, R. N., Gavan, T. L., Gerlach, E. H., Sommers, H. M. Cefotaxime:in vitro activity and tentative interpretive standards for disk susceptibility testing. Antimicrob. Agents Chemother. 18 (1980) 88\u201393.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR27","first-page":"2","volume":"Suppl.","author":"H. M. Ericsson","year":"1971","unstructured":"Ericsson, H. M., Sherris, J. C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol. Microbiol. Scand. Sect. B Suppl. (1971) 2\u201390.","journal-title":"Acta Pathol. Microbiol. Scand. Sect. B"},{"issue":"Suppl.","key":"CR28","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1093\/clinids\/4.Supplement_2.S481","volume":"4","author":"C. R. Smith","year":"1982","unstructured":"Smith, C. R. Cefotaxime and cephalosporins: adverse reactions in perspective. Rev. Infect. Dis. 4 Suppl. (1982) S481-S488.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl.","key":"CR29","doi-asserted-by":"crossref","first-page":"S316","DOI":"10.1093\/clinids\/4.Supplement_2.S316","volume":"4","author":"C. Thornsberry","year":"1982","unstructured":"Thornsberry, C., Jones, R. N., Barry A. L., Fuchs, P. C. Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response. Rev. Infect. Dis. 4 Suppl. (1982) S316-S324.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl.","key":"CR30","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1093\/clinids\/4.Supplement_2.S379","volume":"4","author":"R. M. J. Ings","year":"1982","unstructured":"Ings, R. M. J., Fillastre, J. P., Godin, M., Leroy, A., Humbert, G. The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function. Rev. Infect. Dis. 4 Suppl. (1982) S379-S391.","journal-title":"Rev. Infect. Dis."},{"key":"CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AAC.17.1.84","volume":"17","author":"R. Wise","year":"1980","unstructured":"Wise, R., Wills, P. J., Andrews, J. M., Bedford, K. A. Activity of the cefotaxime (HR 756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins. Antimicrob. Agents Chemother. 17 (1980) 84\u201386.","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01644214\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T08:30:39Z","timestamp":1557217839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01644214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":31,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["BF01644214"],"URL":"https:\/\/doi.org\/10.1007\/bf01644214","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]}}}